Pharmaceuticals are indispensable to contemporary life. Recently, the emerging problem of pharmaceutical-based pollution of river environments, including drinking water sources and lakes, has begun to receive signiˆcant attention worldwide. Because pharmaceuticals are designed to perform speciˆc physiological functions in targeted regions of the human body, there is increasing concern regarding their toxic eŠects, even at low concentrations, on aquatic ecosystems and human health, via residues in drinking water. Pharmaceuticals are consistently employed in hospitals to treat disease; and Japan, one of the most advanced countries in medical treatment, ranks second worldwide in the quantity of pharmaceuticals employed. Therefore, the development of technologies that minimize or lessen the related environmental risks for clinical eOEuent is an important task as well as that for sewage treatment plants (STPs). However, there has been limited research on clinical eOEuent, and much remains to be elucidated. In light of this, we are investigating the occurrence of pharmaceuticals, and the development of water treatment systems for clinical eOEuent. This review discusses the current research on clinical eOEuent and the development of advanced water treatment systems targeted at hospital eOEuent, and explores strategies for future environmental risk assessment and risk management.
Anti-viral 
